Literature DB >> 8524267

Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?

P C Mol1, R H Wang, D W Batey, L A Lee, C V Dang, S L Berger.   

Abstract

The Myc protein has been reported to activate transcription of the rat prothymosin alpha gene by binding to an enhancer element or E box (CACGTG) located in the first intron (S. Gaubatz et al., Mol. Cell. Biol. 14:3853-3862, 1994). The human prothymosin alpha gene contains two such motifs: in the promoter region at kb -1.2 and in intron 1, approximately 2 kb downstream of the transcriptional start site in a region which otherwise bears little homology to the rat gene. Using chloramphenicol acetyltransferase (CAT) reporter constructs driven either by the 5-kb human prothymosin alpha promoter or by a series of truncated promoters, we showed that removal of the E-box sequence had no effect on transient expression of CAT activity in mouse L cells. When intron 1 of the prothymosin alpha gene was inserted into the most extensive promoter construct downstream of the CAT coding region, a diminution in transcription, which remained virtually unchanged upon disruption of the E boxes, was observed. CAT constructs driven by the native prothymosin alpha promoter or the native promoter and intron were indifferent to Myc; equivalent CAT activity was observed in the presence of ectopic normal or mutant Myc genes. Similarly, expression of a transiently transfected wild-type prothymosin alpha gene as the reporter was not affected by a repertoire of myc-derived genes, including myc itself and dominant or recessive negative myc mutants. In COS-1 cells, equivalent amounts of the protein were produced from transfected prothymosin alpha genes regardless of whether genomic E boxes were disrupted, intron 1 was removed, or a repertoire of myc-derived genes was included in the transfection cocktail. More importantly, cotransfection of a dominant negative Max gene failed to reduce transcription of the endogenous prothymosin alpha gene in COS cells or the wild-type transfected gene in COS or L cells. Taken together, the data do not support the idea that Myc activates transcription of the intact human prothymosin alpha gene or reporter constructs that mimic its structure. Rather, they suggest that the human prothymosin alpha promoter and downstream elements are buffered so as to respond poorly, if at all, to transient fluctuations in transcription factors which regulate other genes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524267      PMCID: PMC230955          DOI: 10.1128/MCB.15.12.6999

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

1.  Identification of a low-Mr acidic nuclear protein as prothymosin alpha.

Authors:  J Palvimo; A Linnala-Kankkunen
Journal:  FEBS Lett       Date:  1990-12-17       Impact factor: 4.124

2.  Evidence for nuclear targeting of prothymosin and parathymosin synthesized in situ.

Authors:  M Clinton; L Graeve; H el-Dorry; E Rodriguez-Boulan; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

3.  Enzymes for modifying and labeling DNA and RNA.

Authors:  F Cobianchi; S H Wilson
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Determination of the c-MYC DNA-binding site.

Authors:  T D Halazonetis; A N Kandil
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

5.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

Authors:  E M Blackwood; R N Eisenman
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

6.  Sequence-specific DNA binding by the c-Myc protein.

Authors:  T K Blackwell; L Kretzner; E M Blackwood; R N Eisenman; H Weintraub
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

7.  Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation.

Authors:  G C Prendergast; D Lawe; E B Ziff
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

Review 8.  c-myc oncoprotein function.

Authors:  C V Dang
Journal:  Biochim Biophys Acta       Date:  1991-12-10

9.  Nuclear targeting of prothymosin alpha.

Authors:  R E Manrow; A R Sburlati; J A Hanover; S L Berger
Journal:  J Biol Chem       Date:  1991-02-25       Impact factor: 5.157

10.  The MYC protein activates transcription of the alpha-prothymosin gene.

Authors:  M Eilers; S Schirm; J M Bishop
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

View more
  3 in total

1.  Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer.

Authors:  C Magdalena; F Dominguez; L Loidi; J L Puente
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

2.  Identification of the β-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells.

Authors:  Yi-Te Lin; Chuck C-K Chao
Journal:  Oncotarget       Date:  2015-11-17

3.  Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma.

Authors:  C G Wu; N A Habib; R R Mitry; P H Reitsma; S J van Deventer; R A Chamuleau
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.